Bausch + Lomb shakes up executive team

Eye health company Bausch + Lomb has expanded its executive team, adding Bob Bailey as its executive vice president and chief legal officer and Andrew Stewart as its president of ophthalmic pharmaceuticals. 

Advertisement

Christina Ackermann will step down from the roles of general counsel and president of ophthalmic pharmaceuticals and leave Bausch + Lomb on April 28, according to an April 12 press release. 

Mr. Bailey previously served at Bausch + Lomb for 18 years earlier in his career. He and Mr. Stewart, who most recently served as general manager of AbbVie’s eye care franchise, both have more than 25 years of experience in the healthcare industry. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Ophthalmology

  • East Lansing-based Michigan Surgical Center has disclosed a data breach that may have exposed personal information, according to a July…

  • Cincinnati-based MidWest Eye Center welcomed Alec Bradley, MD, an ophthalmologist who specializes in premium cataract surgery, refractive surgery, microinvasive glaucoma…

Advertisement

Comments are closed.